KDI: Dialyzer, High Permeability With Or Without Sealed Dialysate System

Product code KDI, “Dialyzer, High Permeability With Or Without Sealed Dialysate System” in FDA's classification database, is a Class II device type under 21 CFR 876.5860 (high permeability hemodialysis system), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 345 clearances under KDI, 100 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
KDI
Regulation
21 CFR 876.5860
Class
II
Panel
Gastroenterology, Urology
Clearances
345
Most recent
Jul 24, 2026
Median review, last 2 years
191 days
Third-party review
Not eligible
Implant
No

What it covers

A high permeability hemodialysis system is a device intended for use as an artificial kidney system for the treatment of patients with renal failure, fluid overload, or toxemic conditions by performing such therapies as hemodialysis, hemofiltration, hemoconcentration, and hemodiafiltration. Using a hemodialyzer with a semipermeable membrane that is more permeable to water than the semipermeable membrane of the conventional hemodialysis system (§ 876.5820), the high permeability hemodialysis system removes toxins or excess fluid from the patient's blood using the principles of convection (via a high ultrafiltration rate) and/or diffusion (via a concentration gradient in dialysate). During treatment, blood is circulated from the patient through the hemodialyzer's blood compartment, while the dialysate solution flows countercurrent through the dialysate compartment. In this process, toxins and/or fluid are transferred across the membrane from the blood to the dialysate compartment. The hemodialysis delivery machine controls and monitors the parameters related to this processing, including the rate at which blood and dialysate are pumped through the system, and the rate at which fluid is removed from the patient. The high permeability hemodialysis system consists of the following devices:

(1) The hemodialyzer consists of a semipermeable membrane with an in vitro ultrafiltration coefficient (Kuf) greater than 8 milliliters per hour per conventional millimeter of mercury, as measured with bovine or expired human blood, and is used with either an automated ultrafiltration controller or anther method of ultrafiltration control to prevent fluid imbalance.

(2) The hemodialysis delivery machine is similar to the extracorporeal blood system and dialysate delivery system of the hemodialysis system and accessories (§ 876.5820), with the addition of an ultrafiltration controller and mechanisms that monitor and/or control such parameters as fluid balance, dialysate composition, and patient treatment parameters (e.g., blood pressure, hematocrit, urea, etc.).

(3) The high permeability hemodialysis system accessories include, but are not limited to, tubing lines and various treatment related monitors (e.g., dialysate pH, blood pressure, hematocrit, and blood recirculation monitors).

The identification in 21 CFR 876.5860, high permeability hemodialysis system. FDA gives KDI no definition of its own, so the regulation’s describes it.

FDA flags KDI devices as life-sustaining or life-supporting.

Recent clearances

510(k)DeviceApplicantDecisionType
K261267Careflux H60;Careflux H70;Careflux V500Fresenius Medical Care Renal Therapies Group, LLCJul 24, 2026Traditional
K252377NxStage System One with NxViewFresenius Medical Care Renal Therapies Group, LLCMay 15, 2026Traditional
K260533ELISIO™-HNipro Medical CorporationMar 19, 2026Special
K252459multiFlux 130 (F00013123); multiFlux 160 (F00013124)Fresenius Medical Care Renal Therapies Group, LLCFeb 10, 2026Traditional
K253412Tablo Hemodialysis System (PN-0008000, PN-0006000U)Outset Medical, Inc.Jan 26, 2026Traditional
K253518FX CorAL 40; FX CorAL 50Fresenius Medical Care Renal Therapies Group, LLCDec 18, 2025Special
K243920Purema H Hemoconcentrator - PediatricMedica USA, Inc.Sep 19, 2025Traditional
K250508AK 98 Dialysis Machine (955607)Vantive US Healthcare, LLCAug 1, 2025Traditional
K2432372008T HD SYS. CDX BLUESTAR (191124); 2008T HD SYS. CDX W/bibag BLUESTAR (191126); 2008T HD SYS. W/O CDX BLUESTAR (191128); 2008T HD SYS. W/O CDX W/bibag BLUESTAR (191130)Fresenius Medical Care Renal Therapies Group, LLCJun 13, 2025Traditional
K2435055008X Hemodialysis SystemFresenius Medical Care Renal Therapies Group, LLCMay 30, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 345 with a free account)

Clearances by year

100 KDI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)5118
20259199
20247235
20237157
20227259
20212207
20209266
20194263
20182197
20178188
20165230
2015569
20148164
201311247
20126153
2011585

Who submits

33 applicants cleared a KDI device since 2011. 84% of the clearances went to applicants in United States, then Italy (4%), Japan (4%) and Germany (3%). By type: Traditional 83%, Special 16% and Abbreviated 1%.

ApplicantClearances since 2011
Fresenius Medical Care Renal Therapies Group, LLC19
Nxstage Medical, Inc.13
Nipro Medical Corporation8
Outset Medical, Inc.8
Fresenius Medical Care North America6
Baxter Healthcare Corporation5
Gambro Renal Products, Inc.4
Asahi Kasei Medical Co., Ltd.3

How FDA classifies it

Class II. The special controls for this device are FDA's:

(1) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Device—Part I: Evaluation and Testing,’ ”

(2) “Guidance for the Content of 510(k)s for Conventional and High Permeability Hemodialyzers,”

(3) “Guidance for Industry and CDRH Reviewers on the Content of Premarket Notifications for Hemodialysis Delivery Systems,”

(4) “Guidance for the Content of Premarket Notifications for Water Purification Components and Systems for Hemodialysis,” and

(5) “Guidance for Hemodialyzer Reuse Labeling.”

From 21 CFR 876.5860. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 876.5860 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KDI clearances declared.

Ask about KDI

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about KDI

What is FDA product code KDI?

Product code KDI, “Dialyzer, High Permeability With Or Without Sealed Dialysate System” in FDA's classification database, is a Class II device type under 21 CFR 876.5860 (high permeability hemodialysis system), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 345 clearances under KDI, 100 of them since 2011.

How many 510(k) clearances are there under KDI?

FDA’s 510(k) database listed 345 clearances under KDI as of Oct 29, 2026, 100 of them decided since 2011; the most recent decision was Jul 24, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a KDI 510(k)?

For the 14 KDI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 191 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most KDI clearances?

Since 2011: Fresenius Medical Care Renal Therapies Group, LLC (19), Nxstage Medical, Inc. (13), Nipro Medical Corporation (8), Outset Medical, Inc. (8) and Fresenius Medical Care North America (6). 33 applicants have cleared a KDI device in that time.

Sources

  1. FDA product classification: KDI · Product Classification database
  2. 21 CFR 876.5860: High permeability hemodialysis system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for KDI · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow KDIGet an email when FDA clears, recalls or publishes guidance for KDI devices.

Know what FDA already cleared.